[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: the control group will receive standard treatment. In addition will receive placebo. The placebo prepared by Farabi Pharmaceutical Company will be taken orally three times a day ( every 8 hours) for 72 hours.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: The intervention group will receive standard treatment. In addition The intervention group will receive 400 mg oral pentoxifylline tablets made in Iran, Farabi Pharmaceutical Company with generic code 00970, three times a day ( every 8 hours) for 72 hours", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 971, "treatment_name": "Pentoxifylline", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]